Company research
Lifeward Ltd.
CIK 1607962Updated Sep 24, 2026
SecurityLFWD · NASDAQ · equity
Historical securities (1)
RWLK · OTC · equity · closed Jan 29, 2024Name history
ReWalk Robotics Ltd. · through Sep 16, 2024Argo Medical Technologies Ltd. · through May 16, 2014
LFWD price & chart
Loading TradingView…
NASDAQ:LFWD on TradingView ↗In the news
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026 ↗
Recent filings
PRE 14A filing
Shareholder Director Nominations
Items 5.08
Regulation FD Disclosure
Items 7.01, 9.01
3 filing
8-K filing
Show 5 more recent filings
4 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
10-Q filing
Results of Operations and Financial Condition · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 2.02, 5.02, 9.01
EFFECT filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 22,900,000Source | 30,487,000Source | 63,192,000Source | 74,236,000Source |
| Property, Plant and Equipment, NetUSD | 585,000Source | 867,000Source | 1,262,000Source | 196,000Source |
| GoodwillUSD | 4,755,000Source | 7,538,000Source | 7,538,000Source | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,169,000Source | 6,746,000Source | 28,083,000Source | 67,896,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 6,138,000Source | 6,004,000Source | 3,120,000Source | 1,036,000Source |
| Inventory, NetUSD | 5,732,000Source | 6,723,000Source | 5,653,000Source | 2,929,000Source |
| Assets, CurrentUSD | 15,807,000Source | 21,294,000Source | 39,222,000Source | 72,510,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,528,000Source | 1,624,000Source | 2,366,000Source | 649,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,544,000Source | 548,000Source | 1,861,000Source | 836,000Source |
| Other Assets, NoncurrentUSD | 209,000Source | 240,000Source | 784,000Source | 694,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 14,492,000Source | 11,638,000Source | 16,682,000Source | 6,071,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 9,418,000Source | 4,590,000Source | 4,487,000Source | 4,489,000Source |
| Additional Paid in CapitalUSD | 286,932,000Source | 282,287,000Source | 281,109,000Source | 279,857,000Source |
| Retained Earnings (Accumulated Deficit)USD | -284,739,000Source | -264,825,000Source | -235,883,000Source | -213,750,000Source |
| Stockholders' Equity Attributable to ParentUSD | 8,408,000Source | 18,849,000Source | 46,510,000Source | 68,165,000Source |
| Liabilities and EquityUSD | 22,900,000Source | 30,487,000Source | 63,192,000Source | 74,236,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 12,039,000Source | 10,225,000Source | 11,795,000Source | 4,782,000Source |
| Operating Lease, Liability, CurrentUSD | 425,000Source | 858,000Source | 1,296,000Source | 564,000Source |
| Accounts Payable, CurrentUSD | 5,590,000Source | 5,022,000Source | 5,069,000Source | 1,950,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,159,000Source | 22,000Source | 607,000Source | 333,000Source |
| Other Liabilities, NoncurrentUSD | 61,000Source | 67,000Source | 58,000Source | 66,000Source |
| Additional Financial Items | ||||
| Accounts Receivable, after Allowance for Credit LossUSD | 6,138,000Source | 6,004,000Source | 3,120,000Source | — |
| Deferred Revenue, CurrentUSD | 920,000Source | 1,248,000Source | 1,504,000Source | 301,000Source |
| Deferred Revenue, NoncurrentUSD | 1,233,000Source | 1,324,000Source | 1,506,000Source | 890,000Source |
| Deferred Tax Liabilities, NetUSD | 1,342,000Source | 198,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 19,900,000Source | — | — | -19,569,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 743,000Source | 1,281,000Source | 1,328,000Source | 993,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 134,000Source | 2,884,000Source | 311,000Source | 408,000Source |
| Increase (Decrease) in InventoriesUSD | -896,000Source | 920,000Source | 277,000Source | 117,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | 0Source | 0Source | 316,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -16,826,000Source | -21,718,000Source | -20,667,000Source | -17,891,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 0Source | 0Source | 18,068,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -16,000Source | 0Source | -18,149,000Source | -25,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 16,000Source | 0Source | 81,000Source | 25,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 12,203,000Source | 0Source | -992,000Source | -2,500,000Source |
| Repayments of Long-term DebtUSD | — | — | — | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -4,529,000Source | -21,684,000Source | -39,763,000Source | -20,495,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,579,000Source | 7,108,000Source | 28,792,000Source | 68,555,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | 0Source |
| Income Taxes Paid, NetUSD | 36,000Source | -7,000Source | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 34,000Source | 45,000Source | -79,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 743,000Source | 1,281,000Source | 1,328,000Source | 993,000Source |
| Amortization of Intangible AssetsUSD | 0Source | 3,347,000Source | 1,608,000Source | — |
| DepreciationUSD | 333,000Source | 494,000Source | 239,000Source | 202,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 110,000Source | 34,000Source | — | -79,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 197,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 0Source |
| General and Administrative ExpenseUSD | 8,195,000Source | 5,195,000Source | 9,995,000Source | 7,134,000Source |
| GoodwillUSD | 4,755,000Source | 7,538,000Source | 7,538,000Source | — |
| Goodwill and Intangible Asset ImpairmentUSD | 2,783,000Source | — | — | — |
| Impairment of Intangible Assets, Finite-livedUSD | — | 9,178,000Source | — | — |
| Income Tax Expense (Benefit)USD | -55,000Source | 43,000Source | -12,000Source | 467,000Source |
| Inventory Write-downUSD | 539,000Source | 981,000Source | 398,000Source | 502,000Source |
| Net Income (Loss) Attributable to ParentUSD | -19,914,000Source | -28,942,000Source | -22,133,000Source | -19,569,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -19,569,000Source |
| Operating ExpensesUSD | 28,102,000Source | 37,563,000Source | 28,065,000Source | 21,007,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 22,034,000Source | 25,663,000Source | 13,854,000Source | 5,511,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -19,674,000Source | -29,347,000Source | -23,612,000Source | -19,102,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -19,969,000Source | -28,899,000Source | -22,145,000Source | -19,102,000Source |
| Income Tax Expense (Benefit)USD | -55,000Source | 43,000Source | -12,000Source | 467,000Source |
| Net Income (Loss) Attributable to ParentUSD | -19,914,000Source | -28,942,000Source | -22,133,000Source | -19,569,000Source |
| Earnings Per Share, BasicUSD per share | -17.16Source | -3.33Source | -0.37Source | -0.31Source |
| Earnings Per Share, DilutedUSD per share | -17.16Source | -3.33Source | -0.37Source | -0.31Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 1,160,521Source | 8,691,271Source | 59,719,064Source | 62,378,797Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 1,160,521Source | 8,691,271Source | 59,719,064Source | 62,378,797Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 0Source | 3,347,000Source | 1,608,000Source | — |
| Business Combination, Acquisition Related CostsUSD | — | 2,500,000Source | 2,500,000Source | — |
| Current Income Tax Expense (Benefit)USD | -55,000Source | 43,000Source | -12,000Source | 151,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 110,000Source | 34,000Source | — | -79,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 197,000Source | — | — | — |
| General and Administrative ExpenseUSD | 8,195,000Source | 5,195,000Source | 9,995,000Source | 7,134,000Source |
| Gross ProfitUSD | 8,428,000Source | 8,216,000Source | 4,453,000Source | 1,905,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -19,316,000Source | -15,022,000Source | -19,638,000Source | -19,110,000Source |
| Interest Income (Expense), NetUSD | -312,000Source | 0Source | 11,000Source | — |
| Interest Income, OtherUSD | — | 643,000Source | 1,354,000Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -19,569,000Source |
| Operating ExpensesUSD | 28,102,000Source | 37,563,000Source | 28,065,000Source | 21,007,000Source |
| Research and Development ExpenseUSD | 3,249,000Source | 4,625,000Source | 4,148,000Source | 4,031,000Source |
| Selling and Marketing ExpenseUSD | 13,875,000Source | 17,949,000Source | 13,922,000Source | 9,842,000Source |